33rd European Congress of Pathology
Pathology: Compass for optimal patient therapy
29 - 31 August 2021 | virtual
European Society of Pathology (ESP)
33rd European Congress of Pathology
Congress
ECP 2019 Nice
Presentations
Congress
General Information
Downloads
Related Meetings / Media Partners
Welcome Address
Committees & Organiser
CME Accreditation
Congress Newsletter
ECP 2019 Nice
Gallery
Presentations
Industry Symposia
Abstracts
Guidelines for Submission
Bursaries
Registration
Registration Fees
Group Registration
Online Registration
Scientific Programme
Scientific Contents
Topics
Molecular Pathology Diagnostics Symposium
Preliminary Programme
Sponsors & Exhibitors
General Information
Acknowledgements
My Account
6 steps to your congress registration
Create Account
Congress Account
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Monday, 9 September 2019
08:30 - 12:00
LC-02 | Pulmonary Pathology: Pleural tumours: biomarkers and new entities
LC-02-001-New insights in the diagnosis of mesothelioma
LC-02-003-Are there any new tissue biomarkers useful for diagnosis?
LC-02-004-Pathological grading of malignant pleural mesothelioma
LC-03 | Dermatopathology: Update in cutaneous soft tissue tumours
LC-03-001-Update in cutaneous fibrohistiocytic tumours
LC-03-003-Update in cutaneous tumours of uncertain histogenesis
LC-03-004-Update in cutaneous soft tissue tumours in children
LC-03-005-Questions on update on cutaneous neural tumours
MD-01 | Selected abstracts
MD-01-001-Plasma cfDNA testing of patienswith EGFR mutant non-small cell lung cancer
MD-01-002-Circulating Cell-free DNA in archived low quality volume serum samples: Rate of concordance with mutation in tumor
MD-01-003-Global delivery of external quality assessment for lung cancer liquid biopsy testing
OFP-04 | Breast Pathology
OFP-04-001-Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
OFP-04-003-The prognostic value of the tumour-stroma ratio validates in subgroups of breast cancer, especially in grade III tumours.
OFP-04-004-High Pregnane-X-Receptor (PXR) expression is correlated with poor prognosis in invasive breast carcinoma
OFP-04-005-The immune microenvironment in young patients with Triple Negative Breast Cancer
OFP-04-007-Correlation of the results of Ki67 in intristic subtypes of invasive breast carcinomas with the effect of systemic neoadjuvant treatment
OFP-04-008-Independent HER2-targeted therapy resistance predictors: intratumoural heterogeneity in breast carcinoma HER2 gene copy number and protein expression
OFP-04-009-Investigation of microRNA expression profiles related to morphological heterogeneity in triple-negative breast cancer
OFP-04-010-Ultra-fast and automated immunohistofluorescent multistaining using a microfluidic tissue processor
OFP-04-011-PD-L1 testing in triple negative breast cancer
OFP-04-012-Automatic quantification of HER2 amplification in invasive breast cancer using chromogenic in situ hybridization (CISH) and computational pathology
OFP-04-014-The impact of standardised structured reporting of pathology reports for breast cancer in the Netherlands
OFP-04-015-Correlation between primary tumour and axillary lymph node response to neoadjuvant chemotherapy in breast cancer patients
SC-04 | Joint Session Digestive Diseases Pathology & Rodger Haggitt Pathological Society: Syndromic polyps of the GI tract
SC-04-001-Gastric polyposis syndromes including neuroendocrine tumours
SC-04-002-Mesenchymal syndromic polyposes
SC-04-003-FAP, MAP and PPAP
SC-04-004-"Hamartomatous" polyposes
SC-04-005-Syndromic serrated lesions of the colon
SY-10 | Haematopathology: Technical advances in lymphoma diagnosis
SY-10-001-Mutational analysis vs cell of origin in diffuse large B-cell lymphoma, one or both?
SY-10-003-Traditional FISH or NGS approach?
SY-10-005-Mutational panel diagnosis for MDS/MPN, which panel to use?
SY-11 | Joint Session Paediatric and Perinatal Pathology / Uropathology: Unusual tumours of the kidney and urinary tract in children and adults
SY-11-001-RCC in children and young adults
SY-11-002-Urothelial tumours in children and young adults
SY-11-004-Rhabdomyosarcoma of genitourinary organs
SY-11-005-Other sarcomas of the kidney and GU tract
SY-12 | Neuropathology: Mixed neuronal-glial tumours
SY-12-001-Most frequent benign mixed neuronal-glial tumours
SY-12-004-New FISH tools in diagnosis of neuronal-glial tumours
12:15 - 13:00
KL-02 | Keynote Lecture by Jeroen van der Laak
KL-02-001-The rise of artificial intelligence and its impact on histopathology
14:45 - 16:45
MD-03 | Quality assurance and guidelines in molecular pathology
MD-03-001-ESP EQAs: impact on quality improvement
MD-03-003-IQN PATH: ring trial on liquid biopsy - introduction of trial concept
MD-03-004-IQN PATH: ring trial on liquid biopsy - results from the ESP-EQA
MD-03-005-UK NEQAS: NGS, variant nomenclature and reporting
MD-03-006-French quality assurance programme Gen&tiss
SC-05 | Joint Session Digestive Diseases Pathology & Hans Popper Hepatopathology Society: Hepatocellular carcinoma: from the basic to the complex
SC-05-001-HCC: pathogenesis, epidemiology, and diagnosis
SC-05-002-Classical histology vs. molecular pathology of HCC
SC-05-004-Immune checkpoint inhibitors in HCC: new data
SC-05-005-Cholangiolocarcinomas: where we are now
SC-06 | Dermatopathology: Update in adnexal tumours
SC-06-001-Update in sweat gland tumours
SC-06-002-Update in anogenital mammary-type gland tumours
SC-06-004-Update in sebaceous tumours
SS-04 | Haematopathology: The shifting sands of reactive vs. malignant lymphoproliferations
SS-04-001-Case 1
SS-04-002-Case 2
SS-04-003-Case 3
SS-04-004-Case 4
SS-04-006-Case 6
SS-04-008-Case 8
SS-05 | National Societies: Wolf in sheep's clothing or vice versa?
SS-05-002-Case 2
SS-05-003-Case 3
SS-05-004-Case 4
SS-05-005-Case 5
SS-05-006-Case 6
SY-13 | Pulmonary Pathology: Inside the void: cystic lung diseases
SY-13-001-Cystic lung lesions - the radiologist says: "My approach is..."
SY-13-002-Cystic lung lesions - the pathologist says: "My approach is..."
SY-13-003-Cystic lung lesions in pediatric population
SY-13-004-Rare lung cystic lesions (light chain disease, amiloidosis, Birt-Hogg-Dubé and metastasis)
SY-14 | Joint Session Neuropathology / Electron Microscopy: Storage diseases and neuropathology: diagnosis and new treatment strategies
SY-14-001-Storage disease and myopathies: diagnosis and therapeutic approach
SY-14-002-Myofibrillar myopathies and other disorders with protein accumulation?
SY-15 | IT in Pathology: Guidelines and gold standards in digital pathology
SY-15-001-Guidelines of the German Professional Association
SY-15-003-Present stage of DICOM in virtual pathology
17:15 - 19:15
MD-04 | NGS - beyond mutation testing
MD-04-001-AMP guidelines for variant reporting
MD-04-002-CNV detection from NGS data
MD-04-003-Fusion gene detection using RNAseq
MD-04-004-Moving beyond DNA sequence: genome-wide profiling of plasma DNA
OFP-05 | Digestive Diseases Pathology - Liver / Pancreas
OFP-05-002-A gene expression signature of microvascular invasion in hepatocellular carcinoma in formalin fixed-paraffin embedded biopisies
OFP-05-003-Imaging mass spectrometry to differentiate between pancreatic adenocarcinoma and cholangiocarcinoma
OFP-05-004-Transarterial chemoembolization enhances programmed death-1 and programmed death ligand-1 expression in hepatocellular carcinoma
OFP-05-005-Vessels Encapsulating Tumor Clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma (HCC)
OFP-05-007-SMAD4 deficient pancreatic adenocarcinoma are poor prognosis tumours associated with histopathological aggressive features
OFP-05-009-Expression of GRP78 protein is increased in pancreatic ductal adenocarcinoma, pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm
OFP-05-010-Prognostic value of desmoplastic stroma in intra-hepatic cholangiocarcinoma
OFP-05-011-MSI in intestinal immunophenotype in ampullary and pancreatic cancer
OFP-06 | Joint Session: Endocrine Pathology / Head and Neck Pathology
OFP-06-001-IgG4 thyroiditis: similarity to and differences from IgG4-related disease
OFP-06-002-Is preoperative RAS or BRAF K601E mutations cytologic detection useful for clinical management of indeterminate thyroid nodules, according to the new WHO classification?
OFP-06-005-Immunohistochemical evaluation of CXCR4 chemokine receptor expression in metastatic and nonmetastatic well-differentiated pancreatic neuroendocrine tumours
OFP-06-007-Genetic heterogeneity in adjacent normal mucosa of oral squamous cell carcinoma is a marker of poor prognosis
OFP-06-008-Prognostic impact of DNA methylation analysis in adjacent area of surgically resected oral squamous cell carcinoma during follow up
OFP-06-010-Clinicopathological characterisation and outcomes analysis of a single-institutional cohort of early-stage oral tongue squamous cell carcinoma treated by surgery alone
OFP-06-011-Evaluation of programmed death ligand-1 expression and efficacy outcomes in patients with squamous cell carcinoma of the head and neck from KEYNOTE-040 using two scoring techniques
OFP-06-012-Surgical follow-up of ThyroSeq® positive thyroid nodules: the Memorial Sloan Kettering Cancer Center experience
OFP-07 | Dermatopathology
OFP-07-001-Assessment of circulating tumour cells and circulating cell-free DNA in patients with metastatic melanoma
OFP-07-002-Intravascular nevus cell protrusion and aggregates in otherwise common melanocytic nevi
OFP-07-004-E-cadherin and N-cadherin expression pattern in common melanocytic nevi
OFP-07-005-A PD-L1 IHC 28-8 PharmDX ring trial on metastatic melanoma: practical aspects
OFP-07-006-Imbalance between types I and VI collagen promotes skin fragility in human and experimental diabetes
OFP-07-007-Melanomas with spindle cell differentiation: a review of clinical, pathological and molecular characteristics
OFP-07-008-YAP1 expression in Merkel Cell Carcinoma
OFP-07-009-A 5-year retrospective analysis of all cutaneous metastases from a single dermatopathology unit
OFP-07-011-The role of CD123 positive plasmacytoid dendritic cells in cutaneous lupus erythematosus
OFP-08 | Joint Session: Neuropathology / Ophthalmic Pathology
OFP-08-001-Deregulated expression of imprinted DLK1-DIO3 region in glioblastoma stem-like cells: tumour suppressor role of lncRNA MEG3
OFP-08-002-Ki-67 and MCM6 labelling index are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q codeleted: a multicenter study from the French POLA Network
OFP-08-003-Utra-mutated IDH wild-type glioblastomas in patients younger than 50 years have peculiar histopathology and better prognosis
OFP-08-004-Clinical variability in Gerstmann-Sträussler-Scheinker syndrome with the P102L mutation
OFP-08-006-The quantification of the methylation status of methyl-guanil-methyl-transferase gene (MGMT) by prosequencing from macrodissected paraffin embedded tumours is a relevant prognostic parameter in glioblastoma
OFP-08-007-The place and prognostic value of TERT promoter mutation in molecular classification in grade II-III glial tumours and primary glioblastomas
OFP-08-008-Clinicopathological characterisation of gliomas with H3-K27M mutation: a case series
OFP-08-010-Clinical significance of Ephrin receptor (Eph)-A1, -A5 and -A7 expression in uveal melanoma
OFP-08-011-Histone Deacetylase-2 expression predicts survival in uveal melanoma patients
SC-07 | Haematopathology: Advances in extranodal lymphomas
SC-07-001-Lymphomas in the skin
SC-07-002-Lymphomas of the gastrointestinal tract
SC-07-003-Challenging cases in extranodal lymphomas
SC-07-004-The particular biology of lymphomas in immune privileged sites
SS-06 | Joint Session Pulmonary Pathology / Thymic and Mediastinal Pathology: Rare tumours of mediastinum
SS-06-002-Case 2
SS-06-003-Case 3
SS-06-004-Case 4
SS-07 | Joint Session Nephropathology / Electron Microscopy: Electron microscopy differential diagnosis of glomerular deposits
SS-07-001-Case 1
SS-07-002-Case 2
SS-07-003-Case 3
SS-07-004-Case 4
SS-07-006-Case 6
SS-07-007-Clinical discussion of cases
SY-16 | Joint Session Autopsy Pathology / IT in Pathology: The autopsy: a perspective of education and training in pathology
SY-16-002-From knowledge and understanding to education, research and communication in digital pathology - state of the art and perspectives
SY-16-003-Teaching in the autopsy room; experiences from Texas
SY-16-004-Teaching in the autopsy room; experiences from Poland
SY-16-005-Teaching in the autopsy room, experiences from Denmark and other low-rate countries